Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

0.4612 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 1,432
Open 0.4612
Bid (Size) 0.4612 (800)
Ask (Size) 0.5086 (800)
Prev. Close 0.4612
Today's Range 0.4612 - 0.4612
52wk Range 0.4400 - 6.180
Shares Outstanding 461,285,824
Dividend Yield N/A

Performance

YTD
-36.8%
-36.8%
1 Month
-23.1%
-23.1%
3 Month
-36.8%
-36.8%
6 Month
-48.4%
-48.4%
1 Year
-84.1%
-84.1%

More News

Read More

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 0.4612
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 05/22/26 04:00 PM ET
What is the market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 212.75M
How many shares of Scinai Immunotherapeutics Ltd. - American Depositary Shares are outstanding?
Scinai Immunotherapeutics Ltd. - American Depositary Shares has 213M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.